Evidence map›Paper›PMID 18296523›Full record

ArticleJournal of bacteriology2008

Regulation of the synthesis of the angucyclinone antibiotic alpomycin in Streptomyces ambofaciens by the autoregulator receptor AlpZ and its specific ligand.

Robert Bunet, Marta V Mendes, Nicolas Rouhier, Xiuhua Pang, Laurence Hotel, Pierre Leblond, Bertrand Aigle

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. An aminoacylase activity fromEngineering in life sciences · 2018
    Article
  7. Genome mining of Streptomyces ambofaciens.Journal of industrial microbiology & biotechnology · 2014
    Review
  8. Article
  9. The TetR family of regulators.Microbiology and molecular biology reviews : MMBR · 2013
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Robert BunetLaboratoire de Génétique et Microbiologie, UMR INRA-UHP 1128, IFR 110, Faculté des Sciences et Techniques, Nancy Université, Boulevard des Aiguillettes, BP239, 54506 Vandoeuvre-lès-Nancy, France.
Marta V Mendes
Nicolas Rouhier
Xiuhua Pang
Laurence Hotel
Pierre Leblond
Bertrand Aigle
Interactions Arbres-Microorganismes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptomyces ambofaciens produces an orange pigment and the antibiotic alpomycin, both of which are products of a type II polyketide synthase gene cluster identified in each of the terminal inverted repeats of the linear chromosome. Five regulatory genes encoding Streptomyces antibiotic regulatory proteins (alpV, previously shown to be an essential activator gene; alpT; and alpU) and TetR family receptors (alpZ and alpW) were detected in this cluster. Here, we demonstrate that AlpZ, which shows high similarity to gamma-butyrolactone receptors, is at the top of a pathway-specific regulatory hierarchy that prevents synthesis of the alp polyketide products. Deletion of the two copies of alpZ resulted in the precocious production of both alpomycin and the orange pigment, suggesting a repressor role for AlpZ. Consistent with this, expression of the five alp-located regulatory genes and of two representative biosynthetic structural genes (alpA and alpR) was induced earlier in the alpZ deletion strain. Furthermore, recombinant AlpZ was shown to bind to specific DNA sequences within the promoter regions of alpZ, alpV, and alpXW, suggesting direct transcriptional control of these genes by AlpZ. Analysis of solvent extracts of S. ambofaciens cultures identified the existence of a factor which induces precocious production of alpomycin and pigment in the wild-type strain and which can disrupt the binding of AlpZ to its DNA targets. This activity is reminiscent of gamma-butyrolactone-type molecules. However, the AlpZ-interacting molecule(s) was shown to be resistant to an alkali treatment capable of inactivating gamma-butyrolactones, suggesting that the AlpZ ligand(s) does not possess a lactone functional group.

Indexed as

Gene Expression Regulation, BacterialAmino Acid SequenceAmino Acid SubstitutionAnthraquinonesAnti-Bacterial AgentsBacterial ProteinsBase SequenceDNADNA Mutational AnalysisLigandsMolecular Sequence DataMultigene FamilyPigments, BiologicalReceptors, GABA-ARecombinant ProteinsRepressor Proteins4-butyrolactone receptoralpomycinangucyclinoneAnthraquinonesAnti-Bacterial AgentsBacterial ProteinsDNALigandsPigments, BiologicalReceptors, GABA-ARecombinant ProteinsRepressor Proteins

Identifiers

PMID18296523
PMCPMC2347384
OpenAlexW2102810883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.